News of Note—Commercial production of Portola's Andexxa underway

Woman typing on computer
Here's more about pharma manufacturing. (Max Pixel/CC0)

> Lonza has begun commercial production in Spain of Portola’s second-generation Andexxa, a highly anticipated bleeding antidote for some anticoagulants. Release

> Indian biotech Enzene Biosciences has teamed up with Novasep for a purification installation for its plant in Pune, India, which will allow it to do end-to-end continuous manufacturing of a mAb. Release

> The FDA has gotten a federal court to prevent Ranier’s Compounding Laboratory in Jeanette, Pennsylvania, from making and selling compounded drugs on grounds that it has sold sterile injectables that failed to meet standards. Release

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Suggested Articles

As a key global ingredient supplier, problems in China can ripple worldwide as they have for Swiss CDMO Lonza.

What challenges continue to plague the pharmaceutical industry for almost a decade? Check out this remarkable innovation in glass science that may be the…

WuXi Biologics says its plant in Wuxi, China, has gotten the go-ahead from the FDA to make HIV drug Trogarzo for TaiMed Biologics.